Exelixis, Inc.
EXEL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000939767
In the last 90 days, Exelixis, Inc. insiders filed 0 open-market purchases and 1 sale; 760 institutions reported holding it in 13F filings for Q2 2026, worth $14.1B in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Exelixis, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 366
- −16 vs. Q4 2022
- Shares held
- 280.6M
- +517.7K (+0.2%) vs. Q4 2022
- Total value
- $5.45B
- +$958.2M (+21.3%) vs. Q4 2022
- New holders
- 39
- 134 more added
- Sold out
- 55
- 126 more reduced
6 institutions that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EXEL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 760 | $14.1B |
| Q1 2026 | 701 | $11.1B |
| Q4 2025 | 685 | $11.4B |
| Q3 2025 | 622 | $10.4B |
| Q2 2025 | 635 | $11.2B |
| Q1 2025 | 559 | $9.35B |
| Q4 2024 | 519 | $8.33B |
| Q3 2024 | 454 | $6.45B |
| Q2 2024 | 416 | $5.47B |
| Q1 2024 | 422 | $6.02B |
| Q4 2023 | 427 | $6.21B |
| Q3 2023 | 400 | $5.78B |
| Q2 2023 | 380 | $5.22B |
| Q1 2023 | 366 | $5.45B |
| Q4 2022 | 388 | $4.49B |
| Q3 2022 | 402 | $4.33B |
| Q2 2022 | 376 | $5.78B |
| Q1 2022 | 363 | $6.11B |
| Q4 2021 | 329 | $4.89B |
| Q3 2021 | 341 | $5.63B |
| Q2 2021 | 345 | $4.88B |
| Q1 2021 | 348 | $5.92B |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Exelixis, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| MML Investors Services, LLC | 0 | $0 | 0.00% | −12,702−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −12,145−100.0% | Sold out |
| Park Avenue Securities LLC | 0 | $0 | 0.00% | −11,570−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −10,953−100.0% | Sold out |
| Teza Capital Management LLC | 0 | $0 | 0.00% | −10,971−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −10,842−100.0% | Sold out |
| Cetera Advisor Networks LLC | 0 | $0 | 0.00% | −10,750−100.0% | Sold out |
| Leonteq Securities AG | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Money Concepts Capital Corp | 0 | $0 | 0.00% | −4,235−100.0% | Sold out |
| Natixis | 0 | $0 | 0.00% | −3,705−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −2,400−100.0% | Sold out |
| Atticus Wealth Management, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Beaird Harris Wealth Management, LLC | 0 | $0 | 0.00% | −321−100.0% | Sold out |
| Truvestments Capital LLC | 0 | $0 | 0.00% | −117−100.0% | Sold out |
| Aua Capital Management, LLC | 0 | $0 | 0.00% | −114−100.0% | Sold out |
| Park Place Capital Corp | 0 | $0 | 0.00% | −90−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −40−100.0% | Sold out |
| Montag A & Associates Inc | 0 | $0 | 0.00% | −38−100.0% | Sold out |
| Castleview Partners, LLC | 0 | $0 | 0.00% | −22−100.0% | Sold out |
| Sutton Wealth Advisors Inc. | 0 | $0 | 0.00% | −15−100.0% | Sold out |
| Comerica Securities,inc. | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| Comerica Bank | – | – | – | – | Not filed |
| Alpha Paradigm Partners, LLC | – | – | – | – | Not filed |
| Alaska Permanent Fund Corp | – | – | – | – | Not filed |
| CoreCap Advisors, LLC | – | – | – | – | Not filed |
| Tyler-Stone Wealth Management | – | – | – | – | Not filed |
| Heritage Wealth Management, LLC | – | – | – | – | Not filed |